Crebanine mitigates glucocorticoid‐induced osteonecrosis of the femoral head by restoring bone remodelling homeostasis via attenuating oxidative stress
Open Access
- 28 August 2024
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 28 (16) , e70044
Abstract
The onset of osteonecrosis of the femoral head (ONFH) is intimately associated with the extensive administration of glucocorticoids (GCs). Long‐term stimulation of GCs can induce oxidative stress in both osteoclasts (OCs) and osteoblasts (OBs), resulting in the disturbance of bone remodelling. An alkaloid named crebanine (CN) demonstrates pharmacological properties including anti‐inflammation and reactive oxygen species (ROS) modulation. Our objective is to assess the therapeutic potential of CN in treating ONFH and elucidate the associated underlying mechanisms. The network pharmacology analysis uncovered that CN played a role in regulating ROS metabolism. In vitro, CN demonstrated its ability to reduce the dexamethasone (DEX)‐stimulated generation of OCs and suppress their resorptive function by downregulating the level of osteoclast marker genes. Concurrently, CN also mitigated DEX‐induced damage to OBs, facilitating the restoration of osteoblast marker gene expression, cellular differentiation and function. These effects were achieved by CN augmenting the antioxidant system to reduce intracellular ROS levels. Furthermore, in vitro results were corroborated by micro‐CT and histological data, which also showed that CN attenuated MPS‐induced ONFH in mice. This study highlights the therapeutic potential of CN in counteracting GCs‐induced ONFH.Keywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2021MH264, ZR2021QH077)
- National Natural Science Foundation of China (82100936, 82272485)
This publication has 60 references indexed in Scilit:
- Disorders of Bone RemodelingAnnual Review of Pathology: Mechanisms of Disease, 2011
- From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of OsteoporosisEndocrine Reviews, 2010
- GeneCards Version 3: the human gene integratorDatabase: The Journal of Biological Databases and Curation, 2010
- Phosphorylation of Nrf2 at Multiple Sites by MAP Kinases Has a Limited Contribution in Modulating the Nrf2-Dependent Antioxidant ResponsePLOS ONE, 2009
- Glucocorticoids suppress bone formation via the osteoclastJournal of Clinical Investigation, 2006
- Hyperoxia Stimulates an Nrf2-ARE Transcriptional Response via ROS-EGFR-PI3K-Akt/ERK MAP Kinase Signaling in Pulmonary Epithelial CellsAntioxidants & Redox Signaling, 2006
- Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-κBBiochemical and Biophysical Research Communications, 2004
- Dexamethasone Enhances Osteoclast Formation Synergistically with Transforming Growth Factor-β by Stimulating the Priming of Osteoclast Progenitors for Differentiation into OsteoclastsJournal of Biological Chemistry, 2003
- Osteoclast differentiation and activationNature, 2003
- Oxidants, oxidative stress and the biology of ageingNature, 2000